Planning

Continuous Glucose Monitoring (CGM) in Type 1 Pregnancy

NHS ENGLAND

This public procurement record has 1 release in its history.

Planning

19 Sep 2019 at 15:08

Market Engagement Notice
Summary of the contracting process

The procurement process pertains to NHS England's initiative titled "Continuous Glucose Monitoring (CGM) in Type 1 Pregnancy," aimed at enhancing healthcare for pregnant women with type 1 diabetes. This initiative falls under the healthcare industry category and is centred in the United Kingdom. Currently at the planning stage, NHS England is undertaking early market engagement, with a key engagement deadline set for 1st November 2019. The tender aims to inform potential funding models and commissioning guidance for CGM products, aligning with the NHS Long-Term Plan. A webinar is scheduled for the afternoon of 27th November 2019 to facilitate supplier engagement and gather insights.

This tender provides significant opportunities for businesses involved in the production and supply of medical equipment, particularly those focusing on continuous glucose monitoring systems. Small and medium-sized enterprises (SMEs) and voluntary, community, and social enterprises (VCSEs) are well-suited to participate, as the procurement is looking to understand the market capacity and innovative approaches for CGM distribution. Engaging in this process not only allows for the potential to supply to the NHS but also contributes to enhancing healthcare delivery and outcomes for pregnant women managing type 1 diabetes.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Continuous Glucose Monitoring (CGM) in Type 1 Pregnancy

Notice Description

This Notice solely relates to early market engagement around the development of a CGM in T1 Pregnancy programme, which aims to offer CGM to pregnant women living with type 1 diabetes from 2020/21 as per the NHS Long-Term Plan (LTP) commitment (https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf, pg. 65, paragraph 3.80). This commitment was included following the publishing of the CONCEPTT trial (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32400-5/fulltext), which found that use of CGM throughout pregnancy could support women with type 1 diabetes to achieve better glycaemic control and reduce the risk of adverse neonatal outcomes associated with type 1 diabetes. NHS England wishes to notify CGM suppliers about its intention to commence early market engagement to better understand the current supplier base and market in CGMs, in order to develop a funding model and commissioning guidance to enable delivery of the LTP commitment. This commitment is being delivered as part of NHS England's Diabetes Programme which is a joint partnership between NHS England, Public Health England and Diabetes UK. At this stage, we are not anticipating a central procurement but rather looking to support consistent local adoption at pace and to that end, through a Request for Information (RFI) process and webinar, we are seeking further information to further shape our approach; and to develop a suite of guidance to support Local Health Economies (LHEs), including (but not limited to): a central funding model, associated criteria for LHEs to draw down funding, centrally-issued commissioning guidance (including signposting to CGM products where known). This webinar will be an opportunity for NHS England to summarise the approach and for Suppliers to clarify and ask questions to ultimately support NHS England to develop: 1. An understanding of the suppliers, services and devices available; 2. Criteria for LHEs to access central funding for local commissioning purposes (if this is the route we opt for); 3. Guidance around current capacity and capabilities of the market to meet demand; 4. An understanding of any existing innovative approaches to maximise uptake and use of CGM in T1 pregnancy. 5. Best practice guidance around local commissioning. The webinar is to be held on the afternoon of 27th November 2019 (exact time to be confirmed). To receive further details of the event, please access the following link: https://nhsengland.bravosolution.co.uk/web/login.html Once registered on the portal please access Project 4126 and complete the RFI Questionnaire within PQQ_85 Please also register your interest in attending the webinar by email to england.diabetestreatment@nhs.net. Please note that attendance is limited to a maximum of 2 participants per organisation. For those suppliers who are unable to attend the event, information and a summary of key discussions will be available on request.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-aac6e44d-ffe1-4247-9e03-7d17098d3a12
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/f79e5304-3087-4c46-bb60-3fc24242bc29
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Market Engagement Notice
Procurement Type
Standard
Procurement Category
Not specified
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME, VCSE
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

85 - Health and social work services

CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

85000000 - Health and social work services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
19 Sep 20196 years ago
Submission Deadline
Not specified
Future Notice Date
1 Nov 2019Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Post Town
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-aac6e44d-ffe1-4247-9e03-7d17098d3a12-2019-09-19T16:08:08+01:00",
    "date": "2019-09-19T16:08:08+01:00",
    "ocid": "ocds-b5fd17-aac6e44d-ffe1-4247-9e03-7d17098d3a12",
    "language": "en",
    "initiationType": "tender",
    "title": "Continuous Glucose Monitoring (CGM) in Type 1 Pregnancy",
    "planning": {
        "milestones": [
            {
                "id": "1",
                "title": "Engagement end date",
                "type": "engagement",
                "dueDate": "2019-11-01T23:59:59Z"
            }
        ],
        "documents": [
            {
                "id": "1",
                "documentType": "marketEngagementNotice",
                "description": "Early engagement notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/f79e5304-3087-4c46-bb60-3fc24242bc29",
                "datePublished": "2019-09-19T16:08:08+01:00",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "tender": {
        "id": "tender_219274/799453",
        "title": "Continuous Glucose Monitoring (CGM) in Type 1 Pregnancy",
        "description": "This Notice solely relates to early market engagement around the development of a CGM in T1 Pregnancy programme, which aims to offer CGM to pregnant women living with type 1 diabetes from 2020/21 as per the NHS Long-Term Plan (LTP) commitment (https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf, pg. 65, paragraph 3.80). This commitment was included following the publishing of the CONCEPTT trial (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32400-5/fulltext), which found that use of CGM throughout pregnancy could support women with type 1 diabetes to achieve better glycaemic control and reduce the risk of adverse neonatal outcomes associated with type 1 diabetes. NHS England wishes to notify CGM suppliers about its intention to commence early market engagement to better understand the current supplier base and market in CGMs, in order to develop a funding model and commissioning guidance to enable delivery of the LTP commitment. This commitment is being delivered as part of NHS England's Diabetes Programme which is a joint partnership between NHS England, Public Health England and Diabetes UK. At this stage, we are not anticipating a central procurement but rather looking to support consistent local adoption at pace and to that end, through a Request for Information (RFI) process and webinar, we are seeking further information to further shape our approach; and to develop a suite of guidance to support Local Health Economies (LHEs), including (but not limited to): a central funding model, associated criteria for LHEs to draw down funding, centrally-issued commissioning guidance (including signposting to CGM products where known). This webinar will be an opportunity for NHS England to summarise the approach and for Suppliers to clarify and ask questions to ultimately support NHS England to develop: 1. An understanding of the suppliers, services and devices available; 2. Criteria for LHEs to access central funding for local commissioning purposes (if this is the route we opt for); 3. Guidance around current capacity and capabilities of the market to meet demand; 4. An understanding of any existing innovative approaches to maximise uptake and use of CGM in T1 pregnancy. 5. Best practice guidance around local commissioning. The webinar is to be held on the afternoon of 27th November 2019 (exact time to be confirmed). To receive further details of the event, please access the following link: https://nhsengland.bravosolution.co.uk/web/login.html Once registered on the portal please access Project 4126 and complete the RFI Questionnaire within PQQ_85 Please also register your interest in attending the webinar by email to england.diabetestreatment@nhs.net. Please note that attendance is limited to a maximum of 2 participants per organisation. For those suppliers who are unable to attend the event, information and a summary of key discussions will be available on request.",
        "status": "planning",
        "classification": {
            "scheme": "CPV",
            "id": "33000000",
            "description": "Medical equipments, pharmaceuticals and personal care products"
        },
        "additionalClassifications": [
            {
                "scheme": "CPV",
                "id": "85000000",
                "description": "Health and social work services"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "suitability": {
            "sme": true,
            "vcse": true
        }
    },
    "parties": [
        {
            "id": "GB-CFS-77195",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Quarry House",
                "locality": "Leeds",
                "postalCode": "LS2 7UE",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "england.diabetestreatment@nhs.net"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-77195",
        "name": "NHS England"
    }
}